Search results for "Highlights"


 
Results 111 - 120 of about 248 for "Highlights".
Sort by: Relevance | Newest | Oldest

Elimination diets effective for patients with eosinophilic esophagitis

A systematic review and meta-analysis of 34 studies found that a six-food elimination diet was not significantly better than less restrictive dietary regimens for histological remission and clinical symptom improvement.
https://gastroenterology.acponline.org/archives/2023/02/24/1.htm
24 Feb 2023

Biopsy-proven NAFLD associated with higher rates of MACE

Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
https://gastroenterology.acponline.org/archives/2021/09/24/2.htm
24 Sep 2021

Metabolic syndrome may be linked to pancreatic cancer risk

A nationwide cohort study in Korea found that risk for pancreatic cancer decreased in patients whose metabolic syndrome improved versus persisted over time.
https://gastroenterology.acponline.org/archives/2021/10/22/2.htm
22 Oct 2021

Urinary biomarker may help predict cirrhosis outcomes, study finds

Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021

Pandemic may have led to later presentation of colorectal, breast cancers

A single-center study in California found that more patients presented with stage I disease and fewer presented with stage IV disease in 2019 versus 2020, but the changes were statistically significant only for breast cancer.
https://gastroenterology.acponline.org/archives/2022/02/25/3.htm
25 Feb 2022

Medications for AUD appear beneficial in patients with cirrhosis

A systematic review and meta-analysis found that medications for alcohol use disorder (AUD) were associated with 32% more abstinence versus placebo or standard treatment in patients with alcohol-induced cirrhosis.
https://gastroenterology.acponline.org/archives/2023/09/22/1.htm
22 Sep 2023

Low FODMAP diet beat other dietary interventions for IBS, review finds

A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) ranked first for abdominal pain severity and abdominal bloating or distension severity in irritable bowel syndrome (IBS) but was not superior for bowel habit.
https://gastroenterology.acponline.org/archives/2021/08/27/3.htm
27 Aug 2021

GI bleeding risks with warfarin and DOACs compared

Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022

Use of PPIs may be associated with C. difficile infections

A Danish nationwide cohort study found that ongoing exposure to proton-pump inhibitors (PPIs) was associated with moderately increased community-associated Clostridioides difficile infection risk during treatment and for up to one year afterward.
https://gastroenterology.acponline.org/archives/2021/03/26/3.htm
26 Mar 2021

U.S. antibiotic resistance rates for H. pylori appear high

A systematic review and meta-analysis of resistance patterns of Helicobacter pylori strains found that resistance to metronidazole, levofloxacin, and clarithromycin exceeds 30%.
https://gastroenterology.acponline.org/archives/2022/05/27/1.htm
27 May 2022

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next